The collaborative clinical study will evaluate ADSTILADRIN® (nadofaragene firadenovec-vncg) in combination with the ...
PARSIPPANY, N.J.--(BUSINESS WIRE)--Ferring Pharmaceuticals announced today the U.S. Food and Drug Administration (FDA) approved a state-of-the-art drug product manufacturing hub in Parsippany, NJ, for ...
Before Michel Pettigrew took the reins at Ferring Pharmaceuticals more than a decade ago he admits he didn’t know much about the company, but what he did appreciate was its difference to big pharma.
SAINT PREX, Switzerland--(BUSINESS WIRE)--Ferring Pharmaceuticals presented the first results from an ongoing Phase 3 trial in Japan assessing the efficacy and safety of nadofaragene firadenovec in ...
With its second approval in as many months, Ferring Pharmaceuticals is celebrating a fruitful end to 2022. On Friday, the FDA approved Ferring’s gene therapy Adstiladrin to treat certain patients with ...
Ferring reported annual revenues of €2.2 billion, an increase of +1% at constant exchange rates, supported by robust sales performance in core franchise and legacy products Launches of Rebyota and ...
On the heels of an FDA speedy review for Keytruda’s potential use in non-muscle invasive bladder cancer (NMIBC), its close rival, a gene therapy by Ferring Pharmaceuticals spinout FerGene, has posted ...
InvestorsHub on MSN
Theralase and Ferring ink deal for new bladder cancer study
Theralase Technologies (USOTC:TLTFF) signed a clinical development agreement with Ferring Pharmaceuticals, a top name in ...
Bladder cancer can be treated with several types of drugs. Gene therapy is now part of the mix. The FDA has approved a Ferring Pharmaceuticals gene therapy as a treatment for patients whose cancer is ...
Ferring Pharmaceuticals’ chief operating officer and president of its executive board, Michel Pettigrew, announced that he plans to retire Dec. 31. Chief Science Officer Per Falk, M.D., Ph.D., who ...
You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Cheryl Teh Every time Cheryl publishes a story, you’ll get an alert straight to your inbox!
Ferring Pharmaceuticals and Theralase® Technologies Inc. (TSXV:TLT) (OTCQB:TLTFF) are pleased to announce that they have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results